Y-mAbs Therapeutics logo
Y-mAbs Therapeutics YMAB
$ 8.27 -3.56%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Y-mAbs Therapeutics Financial Ratios 2011-2024 | YMAB

Annual Financial Ratios Y-mAbs Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-33.8 -1.4 -7.1 -14.1 -14.7 -13.5 - - - - - - -

P/S

8.5 2.0 11.3 81.4 - - - - - - - - -

EPS

-0.5 -2.2 -1.3 -3.0 -2.3 -1.5 -1.0 - - - - - -

EV (Enterprise Value)

672 M 60.2 M 244 M 1.6 B 998 M 447 M -80.5 M 5.2 M - - - - -

EBITDA per Share

-0.57 -2.15 -2.66 -2.97 -2.35 -1.5 - - - - - - -

EV/EBITDA

-2.1 -13.2 -11.8 -10.1 - - - - - - -

PEG

- 0.3 0.27 0.08 - - - - - - -

P/B

7.2 1.2 2.2 16.0 6.0 4.2 - - - - - - -

P/CF

-26.6 -1.8 -3.8 -18.5 -15.7 -14.1 - - - - - - -

ROE %

-21.22 -87.50 -30.69 -112.76 -40.74 -30.79 - - - - - - -

ROA %

-16.76 -67.56 -25.98 -90.37 -37.45 -28.48 - - - - - - -

ROCE %

-25.42 -86.81 -64.09 -106.60 -40.93 -30.27 - - - - - - -

Current Ratio

4.8 4.4 6.5 6.3 15.6 16.6 - - - - - - -

DSO

75.3 56.6 40.3 - - - - - - - - - -

DIO

188.9 298.5 436.6 - - - - - - - - - -

DPO

324.9 677.7 1815.8 1552.8 - - - - - - - - -

Operating Cycle

264.2 355.1 476.9 - - - - - - - - - -

Cash Conversion Cycle

-60.7 -322.6 -1338.9 -1552.8 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Y-mAbs Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.16 -0.21 -0.15 - -0.18 -0.14 -0.15 - -0.63 -0.94 -0.64 - -0.66 -0.53 0.8 -0.48 -0.82 -1.01 -0.66 -0.6 -0.7 -0.53 -0.47 -0.42 -0.42 -0.39 -0.28 -0.44 -0.21 -0.18 -0.16 - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

- - -0.15 - - - -0.17 - -0.58 -0.91 -0.63 - -0.65 -0.52 -0.67 - -0.81 -1.01 -0.67 - -0.71 -0.54 -0.47 -0.41 -0.42 -0.38 -0.28 - -0.21 - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

-31.69 -31.86 -28.17 -19.68 -45.19 -62.97 -88.25 -74.64 -88.33 -76.50 -54.99 -10.23 -29.06 -46.40 -74.77 -112.76 -105.55 -86.56 -57.46 -40.74 -39.11 -35.21 -33.48 -30.79 -32.05 -28.58 -21.25 -15.92 -4.66 - - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

-23.60 -23.82 -22.16 -15.42 -34.55 -47.66 -67.80 -58.72 -70.74 -63.64 -47.58 -8.71 -23.81 -36.64 -58.40 -90.37 -85.97 -72.16 -49.91 -37.45 -36.01 -32.48 -30.92 -28.48 -29.27 -25.91 -19.12 -14.20 -4.15 - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

-34.24 -32.71 -29.34 -21.59 -45.71 -62.08 -85.58 -72.10 -85.71 -75.22 -54.51 -34.51 -53.50 -70.73 -99.25 -113.32 -106.28 -87.68 -58.83 -41.73 -39.80 -35.68 -33.61 -30.76 -32.03 -28.59 -21.29 -15.97 -4.68 - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

4.2 3.0 5.1 4.8 4.5 4.8 4.6 4.4 4.0 4.9 5.7 6.5 8.2 10.3 12.1 5.0 5.0 5.0 5.0 12.4 12.4 12.4 12.4 13.3 13.3 13.3 13.3 9.2 9.2 - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

104.1 85.6 98.5 - 84.8 83.2 70.4 - 59.9 69.9 74.1 - 80.3 60.5 50.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

366.4 256.5 294.0 - 216.3 138.7 342.7 - 240.3 495.6 276.6 - 714.0 1100.7 493.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

366.7 256.1 278.2 - 261.3 158.0 504.2 - 461.1 1038.7 703.0 - 1478.8 3044.6 7807.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

470.5 342.1 392.5 - 301.0 221.8 413.1 - 300.2 565.4 350.7 - 794.3 1161.2 543.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

103.8 86.0 114.3 - 39.7 63.9 -91.1 - -160.9 -473.2 -352.3 - -684.5 -1883.4 -7263.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency